Company Filing History:
Years Active: 2023
Title: The Innovations of Albert Snowball
Introduction
Albert Snowball is a notable inventor based in London, GB. He has made significant contributions to the field of biotechnology, particularly through his innovative work on expression vectors. His research focuses on enhancing the treatment of neurological disorders, showcasing the potential of genetic engineering in medicine.
Latest Patents
Albert Snowball holds a patent for "Expression vectors comprising engineered genes." This invention provides expression vectors, nucleic acids, vector particles, and methods of treatment involving these vector particles. The patent specifically includes an engineered KCNA1 gene that encodes an edited Kv1.1 potassium channel. The features of the engineered KCNA1 gene are designed to enhance the translation and activity of the Kv1.1 protein, improving the detection of KCNA1 gene expression in cells. This technology has potential applications in treating epilepsy and similar neurological disorders.
Career Highlights
Albert Snowball is associated with UCL Business Plc, where he continues to develop his innovative ideas. His work has positioned him as a key figure in the intersection of genetics and therapeutic applications. His dedication to advancing medical science through technology is evident in his research and patent contributions.
Collaborations
Some of Albert's notable coworkers include Stephanie Schorge and Matthew Charles Walker. Their collaborative efforts contribute to the ongoing research and development in the field of genetic engineering and its applications in medicine.
Conclusion
Albert Snowball's work exemplifies the impact of innovation in biotechnology. His patented inventions and collaborations highlight the importance of genetic engineering in addressing neurological disorders. His contributions continue to pave the way for advancements in medical treatments.